See the DrugPatentWatch profile for ozempic

Ozempic (generic name: semaglutide) is a medication used to improve blood sugar control in adults with type 2 diabetes. It is a glucagon-like peptide-1 (GLP-1) receptor agonist, which works by mimicking the functions of natural hormones in your body to regulate blood sugar levels [1].

However, there are certain individuals who should avoid using Ozempic or use it with caution. According to the drug's prescribing information, people with the following conditions should not use Ozempic:

1. A personal or family history of medullary thyroid carcinoma (a type of thyroid cancer) [1].
2. Multiple endocrine neoplasia syndrome type 2 (a genetic disorder that can cause tumors in various glands) [1].
3. A history of pancreatitis (inflammation of the pancreas) [1].
4. Diabetic ketoacidosis or a history of ketoacidosis [1].
5. Severe stomach or intestinal problems, such as gastroparesis (a condition where the stomach takes too long to empty its contents) [1].

Additionally, individuals with the following conditions should use Ozempic with caution:

1. Kidney problems [1].
2. A history of alcoholism [1].
3. Pancreatitis [1].

It is essential to consult a healthcare provider to determine if Ozempic is appropriate for an individual's specific medical condition [1].

Sources:
[1] DrugPatentWatch.com. (n.d.). Ozempic (semaglutide) - DrugPatentWatch. Retrieved from <https://www.drugpatentwatch.com/drugs/ozempic>.